BUSINESSTHE HINDU NATIONAL
RBI compounds FEMA violations in Apothecon Pharmaceuticals case
The Reserve Bank of India (RBI) is accused of compounding violations under the Foreign Exchange Management Act (FEMA) in a case involving Apothecon Pharmaceuticals. The case centers on alleged non-compliance with FEMA regulations by the pharmaceutical company.
Mentioned
Related Signal
Adjacent reporting
- Feds lose Supreme Court duel over Twitter-era obstruction probe
- Bengaluru Capgemini creche case: Management claims footage manipulated for blackmail and extortion
- There’s One Big Flaw With The AG’s Track Record On Medicaid Fraud
- FDA finds 'significant violations' committed by major manufacturer of pain relievers, ADHD drugs and anxiety medications